Speranza Therapeutics, Inc. filed a Form C-W (Regulation Crowdfunding) with the SEC on 2022-09-26.
| Name | Role | Location |
|---|---|---|
| Joseph C Bissonnette | Chief Financial Officer and Principle Accounting Officer | — |
| Todd Krasinsky | Chief Strategy Officer and Director | — |
| Sal Rafanelli | President and CEO | — |
| Joseph C Bissonnettee | Chief Financial Officer | — |
| Filed | Form | Target | Max |
|---|---|---|---|
| 2022-05-31 | C/A | $10K | $1.1M |
| 2022-05-02 | C-AR | — | — |
| 2022-04-28 | C/A | $10K | $1.1M |
| 2022-03-31 | C/A | $10K | $1.1M |
| 2022-03-11 | C | $10K | $1.1M |